Generic drug savings by top drug in Canada's public drug plans 2012/2013
This statistic depicts total generic drug savings in Canadian public drug plans in 2012/2013, by top drug. The total savings for Nabilone (Cesamet) in selected Canadian public drug plans amounted to 11.06 million Canadian dollars.